Activating Compound | Comment | Organism | Structure |
---|---|---|---|
tumor necrosis factor-like 1A | - |
Homo sapiens |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
1-(5-Iodonaphthalene-1-sulfonyl)-1H-hexahydro-1,4-diazepine hydrochloride | inhibitor targeting the ATPase domain of the enzyme; inhibitor targeting the ATPase domain of the enzyme | Homo sapiens | |
RKKYKYRRK-NH2 | specific enzyme inhibitor targeting the kinase domain; specific enzyme inhibitor targeting the kinase domain | Homo sapiens |
Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
---|---|---|---|
210000 | - |
gel filtration | Homo sapiens |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + [myosin light chain] | Homo sapiens | - |
ADP + [myosin light chain] phosphate | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | Q15746 | - |
- |
Homo sapiens | Q9H1R3 | - |
- |
Posttranslational Modification | Comment | Organism |
---|---|---|
phosphoprotein | - |
Homo sapiens |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
Caco-2 cell | - |
Homo sapiens | - |
intestinal epithelial cell | - |
Homo sapiens | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + [myosin light chain] | - |
Homo sapiens | ADP + [myosin light chain] phosphate | - |
? |
Synonyms | Comment | Organism |
---|---|---|
MLCK1 | isoform | Homo sapiens |
MLCK2 | isoform | Homo sapiens |
Organism | Comment | Expression |
---|---|---|
Homo sapiens | interferon gamma does not upregulate isoform MLCK1 transcript | additional information |
Homo sapiens | the expression level of the splice variant MLCK1 is significantly increased in actively inflamed tissues of the Crohn's disease and ulcerative colitis patient samples. The splice variant MLCK1 is overexpressed in colonic biopsy specimens of inflammatory bowel disease patients. Treatment with low-dose cytokines tumor necrosis factor-like 1A | up |
Homo sapiens | the expression levels of splice variant MLCK2 is significantly increased in actively inflamed tissues of the Crohn's disease and ulcerative colitis patient samples. The splice variant MLCK2 is overexpressed in colonic biopsy specimens of inflammatory bowel disease patients. Treatment with low-dose cytokines tumour necrosis factor-like 1A and interferon gamma upregulates isoform MLCK2 transcript | up |